B

BioMaxima
BMX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
PLN54.30M
EV
PLN70.17M
Shares Outstanding
4.19M
Beta
0.13
Industry
Medical - Diagnostics & Research

Wall Street View

Analyst Rating
-
Analyst Target Price
-
Number of Analysts
0
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About BioMaxima S.A.

gainify

B

BioMaxima S.A.

BMX

BioMaxima S.A. manufactures and distributes microbiological media, reagents, and equipment for in vitro diagnostics in Poland. Its primary products include analyzers and diagnostic reagents for testing the biochemical parameters of blood and other body fluids; systems...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Urban, Lukasz

Employees

126

IPO Date

2010-07-21

Headquarters

ul. Vetterów 5, Lublin 20-277, Poland

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.